PL3122799T3 - Sposoby wytwarzania poloksameru do stosowania w pożywce do hodowli komórkowej - Google Patents
Sposoby wytwarzania poloksameru do stosowania w pożywce do hodowli komórkowejInfo
- Publication number
- PL3122799T3 PL3122799T3 PL15715932T PL15715932T PL3122799T3 PL 3122799 T3 PL3122799 T3 PL 3122799T3 PL 15715932 T PL15715932 T PL 15715932T PL 15715932 T PL15715932 T PL 15715932T PL 3122799 T3 PL3122799 T3 PL 3122799T3
- Authority
- PL
- Poland
- Prior art keywords
- poloxamer
- preparing
- methods
- culture medium
- cell culture
- Prior art date
Links
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 title 1
- 239000006143 cell culture medium Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960000502 poloxamer Drugs 0.000 title 1
- 229920001983 poloxamer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/50—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing nitrogen, e.g. polyetheramines or Jeffamines(r)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
- C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Peptides Or Proteins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970281P | 2014-03-25 | 2014-03-25 | |
| PCT/US2015/022592 WO2015148736A1 (en) | 2014-03-25 | 2015-03-25 | Methods of preparing a poloxamer for use in cell culture medium |
| EP15715932.8A EP3122799B8 (en) | 2014-03-25 | 2015-03-25 | Methods of preparing a poloxamer for use in cell culture medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3122799T3 true PL3122799T3 (pl) | 2020-06-29 |
Family
ID=52824596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15715932T PL3122799T3 (pl) | 2014-03-25 | 2015-03-25 | Sposoby wytwarzania poloksameru do stosowania w pożywce do hodowli komórkowej |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11034793B2 (OSRAM) |
| EP (2) | EP3122799B8 (OSRAM) |
| JP (3) | JP6655548B2 (OSRAM) |
| KR (1) | KR102352250B1 (OSRAM) |
| CN (2) | CN106414552B (OSRAM) |
| AU (1) | AU2015236008B2 (OSRAM) |
| BR (1) | BR112016021739B1 (OSRAM) |
| CA (1) | CA2943357C (OSRAM) |
| ES (1) | ES2778680T3 (OSRAM) |
| HR (1) | HRP20200372T1 (OSRAM) |
| IL (2) | IL247902B (OSRAM) |
| MX (2) | MX2016012288A (OSRAM) |
| MY (1) | MY178060A (OSRAM) |
| PL (1) | PL3122799T3 (OSRAM) |
| RU (1) | RU2710551C2 (OSRAM) |
| SG (1) | SG11201607929PA (OSRAM) |
| SI (1) | SI3122799T1 (OSRAM) |
| WO (1) | WO2015148736A1 (OSRAM) |
| ZA (1) | ZA201606711B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122799B8 (en) | 2014-03-25 | 2020-03-11 | F.Hoffmann-La Roche Ag | Methods of preparing a poloxamer for use in cell culture medium |
| WO2017157505A1 (en) | 2016-03-17 | 2017-09-21 | Merck Patent Gmbh | Method for purifying poloxamers |
| SG11202002351SA (en) * | 2017-12-21 | 2020-07-29 | Sigma Aldrich Co Llc | Poloxamer compositions and methods of making and using same |
| WO2020013725A1 (en) * | 2018-07-12 | 2020-01-16 | Arshintseva Elena Valentinovna | Thermal method for sterilizing poloxamer comprising liquid drugs |
| KR102853452B1 (ko) * | 2018-07-27 | 2025-09-03 | 아지노모토 가부시키가이샤 | 동물 세포의 부유 배양용 첨가물, 부유 배양용 배지 및 부유 배양 방법 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE266710C (OSRAM) | ||||
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| WO1992003918A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| AU2699892A (en) | 1991-10-04 | 1993-05-03 | Gs Biochem Ab | Particles, method of preparing said particles and uses thereof |
| DK0754050T3 (da) | 1994-01-14 | 2002-10-21 | Xoma Technology Ltd | Anti-gram-positive bakterielle fremgangsmåder og materialer |
| US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
| ATE390933T1 (de) | 1995-04-27 | 2008-04-15 | Amgen Fremont Inc | Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8 |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| GB9625175D0 (en) * | 1996-12-04 | 1997-01-22 | Medi Cult As | Serum-free cell culture media |
| US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| ES2248127T3 (es) | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| TWI367113B (en) * | 2003-02-12 | 2012-07-01 | Syncera Inc | Random and non-random alkylene oxide polymer alloy compositions |
| US8802116B2 (en) * | 2003-02-27 | 2014-08-12 | Novasel Australia Pty. Ltd. | Poloxamer emulsion preparations |
| AU2003900887A0 (en) * | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
| EP1660227B1 (en) * | 2003-08-04 | 2012-05-23 | Camurus Ab | Method for improving the properties of amphiphile particles |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| US20060121016A1 (en) | 2004-10-18 | 2006-06-08 | Lee Raphael C | Methods and compositions for treatment of free radical injury |
| US9149433B2 (en) * | 2004-11-30 | 2015-10-06 | Basf Corporation | Method for formation of micro-prilled polymers |
| CN1939534B (zh) | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
| CN101516339B (zh) | 2006-08-16 | 2012-06-13 | 诺瓦提斯公司 | 制备高度结晶的治疗化合物的固体分散体的方法 |
| KR100932613B1 (ko) | 2007-04-27 | 2009-12-17 | 한남대학교 산학협력단 | 고분자 용융공정을 이용한 약물전달용 생체적합성 고분자나노 미립구의 제조방법 및 그 나노 미립구 |
| WO2009055312A1 (en) * | 2007-10-22 | 2009-04-30 | Dfb Pharmaceuticals, Inc. | Process for producing a poloxamer gel |
| PT2574677T (pt) | 2007-12-27 | 2017-10-19 | Baxalta Inc | Processos para cultura de células |
| BR112012015596B1 (pt) * | 2009-12-23 | 2021-06-01 | Sanofi Pasteur | Processo de cultura de células aderentes |
| EP2830598B1 (en) * | 2012-03-30 | 2016-11-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Microsphere compositions, preparation method and applications thereof |
| EP3122799B8 (en) | 2014-03-25 | 2020-03-11 | F.Hoffmann-La Roche Ag | Methods of preparing a poloxamer for use in cell culture medium |
-
2015
- 2015-03-25 EP EP15715932.8A patent/EP3122799B8/en active Active
- 2015-03-25 HR HRP20200372TT patent/HRP20200372T1/hr unknown
- 2015-03-25 CN CN201580026701.5A patent/CN106414552B/zh active Active
- 2015-03-25 SI SI201531128T patent/SI3122799T1/sl unknown
- 2015-03-25 CA CA2943357A patent/CA2943357C/en active Active
- 2015-03-25 KR KR1020167029244A patent/KR102352250B1/ko active Active
- 2015-03-25 AU AU2015236008A patent/AU2015236008B2/en active Active
- 2015-03-25 EP EP20151556.6A patent/EP3778702B1/en active Active
- 2015-03-25 MX MX2016012288A patent/MX2016012288A/es unknown
- 2015-03-25 RU RU2016141568A patent/RU2710551C2/ru active
- 2015-03-25 SG SG11201607929PA patent/SG11201607929PA/en unknown
- 2015-03-25 WO PCT/US2015/022592 patent/WO2015148736A1/en not_active Ceased
- 2015-03-25 ES ES15715932T patent/ES2778680T3/es active Active
- 2015-03-25 JP JP2016558605A patent/JP6655548B2/ja active Active
- 2015-03-25 MY MYPI2016001715A patent/MY178060A/en unknown
- 2015-03-25 CN CN202010723304.6A patent/CN111808276A/zh active Pending
- 2015-03-25 PL PL15715932T patent/PL3122799T3/pl unknown
- 2015-03-25 BR BR112016021739-0A patent/BR112016021739B1/pt active IP Right Grant
-
2016
- 2016-09-19 IL IL247902A patent/IL247902B/en active IP Right Grant
- 2016-09-22 US US15/273,155 patent/US11034793B2/en active Active
- 2016-09-22 MX MX2021001981A patent/MX2021001981A/es unknown
- 2016-09-28 ZA ZA2016/06711A patent/ZA201606711B/en unknown
-
2020
- 2020-02-04 JP JP2020017136A patent/JP2020103290A/ja not_active Withdrawn
- 2020-12-20 IL IL279583A patent/IL279583B/en unknown
-
2021
- 2021-05-13 US US17/319,886 patent/US11912823B2/en active Active
-
2022
- 2022-09-30 JP JP2022157928A patent/JP7472222B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201608303B (en) | Methods for harvesting mammalian cell cultures | |
| IL250340A0 (en) | Growth media for the culture of pluripotent stem cells | |
| SG11201703493SA (en) | Cell culture insert | |
| GB201507834D0 (en) | Culture medium | |
| IL252114A0 (en) | A bioreactor using macroalgae | |
| SG11201705743YA (en) | Cell culture medium | |
| GB201421094D0 (en) | Culture medium | |
| SG11201703494PA (en) | Devices and methods for generation and culture of 3d cell aggregates | |
| EP3196287A4 (en) | Cell culture apparatus | |
| IL279583B (en) | Methods for preparing poloxamer for use in cell culture medium | |
| SG11201609916RA (en) | Culture method and cell mass | |
| PL3224341T3 (pl) | Materiały i sposoby do przedłużania pożywki do hodowli komórkowej | |
| EP3107996A4 (en) | Tscm cells and methods for use | |
| SG11201608463WA (en) | Method of preparing cells for 3d tissue culture | |
| EP3235900A4 (en) | Cell culture apparatus | |
| IL246525A0 (en) | Pomegranate cell culture and methods for its preparation and use | |
| PL3132020T3 (pl) | Naczynie do hodowli komórek i jego zastosowanie | |
| EP3109312A4 (en) | Cell culture container | |
| IL249202A0 (en) | Cell culture methods and media containing n-acetylcysteine | |
| IL247890A0 (en) | Methods related to stem cells | |
| SG11201702897WA (en) | Cell culture bag and cell culture method | |
| SG11201607384SA (en) | Method for inducing pluripotency in a hematopoietic cell | |
| SG11201609269TA (en) | Method of culturing cells | |
| GB201421342D0 (en) | Cell culture | |
| GB201403622D0 (en) | Mammalian cell storage medium |